Skip to content

BIO-B

BIO-RAD LABORATORIES, INC.

NYSE · Healthcare · Medical - Devices · US

$385.84
+5.69%
Ask drillr

Margins

Gross margin
51.9%
EBITDA margin
20.6%
EBIT margin
9.1%
Net margin
8.6%
FCF margin
13.6%
3.1%
Return on equity
2.2%
Return on assets
2.8%
Return on invested capital
0.26x
Asset turnover
$492.6M
Cash from operations
$61
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026